PRRT2 and myotonic dystrophy type 1: Consistent with this idea, blocking PKC activity with Ro-31-8220 resulted in improvement in a heart-specific DM1 mouse model, and was correlated with reduced phosphorylation and decreased levels of CELF1 [23].